ATE446301T1 - Ausgewählte kondensierte heterocyclen und deren anwendung - Google Patents

Ausgewählte kondensierte heterocyclen und deren anwendung

Info

Publication number
ATE446301T1
ATE446301T1 AT05771781T AT05771781T ATE446301T1 AT E446301 T1 ATE446301 T1 AT E446301T1 AT 05771781 T AT05771781 T AT 05771781T AT 05771781 T AT05771781 T AT 05771781T AT E446301 T1 ATE446301 T1 AT E446301T1
Authority
AT
Austria
Prior art keywords
application
condensed heterocycles
selected condensed
heterocycles
condensed
Prior art date
Application number
AT05771781T
Other languages
English (en)
Inventor
Brian Aquila
Michael Block
Audrey Davies
Jayachandran Ezhuthachan
Timothy Pontz
Daniel Russell
Marie-Elena Theoclitou
Xiaolan Zheng
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35004223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE446301(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE446301T1 publication Critical patent/ATE446301T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05771781T 2004-08-18 2005-08-16 Ausgewählte kondensierte heterocyclen und deren anwendung ATE446301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60239904P 2004-08-18 2004-08-18
PCT/GB2005/003202 WO2006018627A1 (en) 2004-08-18 2005-08-16 Selected fused heterocyclics and uses thereof

Publications (1)

Publication Number Publication Date
ATE446301T1 true ATE446301T1 (de) 2009-11-15

Family

ID=35004223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771781T ATE446301T1 (de) 2004-08-18 2005-08-16 Ausgewählte kondensierte heterocyclen und deren anwendung

Country Status (19)

Country Link
US (1) US20070249636A1 (de)
EP (1) EP1781673B1 (de)
JP (1) JP2008509976A (de)
KR (1) KR20070046175A (de)
CN (1) CN101023086A (de)
AR (1) AR050921A1 (de)
AT (1) ATE446301T1 (de)
AU (1) AU2005273704A1 (de)
BR (1) BRPI0514398A (de)
CA (1) CA2575056A1 (de)
DE (1) DE602005017283D1 (de)
IL (1) IL180811A0 (de)
MX (1) MX2007001954A (de)
NO (1) NO20070980L (de)
RU (1) RU2007109867A (de)
TW (1) TW200621260A (de)
UY (1) UY29074A1 (de)
WO (1) WO2006018627A1 (de)
ZA (1) ZA200701081B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0514390A (pt) 2004-08-18 2008-06-10 Astrazeneca Ab enanciÈmero de um composto ou um sal farmacêuticamente aceitável ou um éster hidrolisável in vivo do mesmo, uso do mesmo, métodos para o tratamento de cáncer, para produzir um efeito inibidor de eg5 em um animal de sangue quente e para tratar doenças, e, composição farmacêutica
JP2008546843A (ja) * 2005-06-27 2008-12-25 アムゲン インコーポレイティッド 抗炎症性アリールニトリル化合物
ES2564826T3 (es) * 2007-06-21 2016-03-29 Neuronascent, Inc. Métodos y composiciones para estimular neurogénesis e inhibir degeneración neuronal utilizando isotiazolopirimidinonas
CN104586832B (zh) * 2007-09-10 2018-02-16 北京强新生物科技有限公司 用于癌症治疗的组合物和方法
JP5455915B2 (ja) 2007-10-19 2014-03-26 メルク・シャープ・アンド・ドーム・コーポレーション Ｋｓｐキネシン活性を阻害するためのスピロ縮合した１，３，４−チアジアゾール誘導体
KR20150139955A (ko) 2013-04-09 2015-12-14 보스톤 바이오메디칼, 인크. 암 치료에 사용하기 위한 2-아세틸나프토[2,3-b]푸란-4,9-디온
JP7106563B2 (ja) 2016-11-29 2022-07-26 スミトモ ファーマ オンコロジー， インコーポレイテッド ナフトフラン誘導体、その調製、および使用方法
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002363960B2 (en) * 2001-12-06 2008-07-10 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
WO2003049679A2 (en) * 2001-12-06 2003-06-19 Merck & Co., Inc. Mitotic kinesin inhibitors
DE60333094D1 (de) * 2002-04-17 2010-08-05 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren
JP3947758B2 (ja) * 2003-03-07 2007-07-25 アストラゼネカ アクチボラグ 新規縮合ヘテロサイクル及びその使用
US7022850B2 (en) * 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
US7345046B2 (en) * 2003-05-30 2008-03-18 Chiron Corporation Heteroaryl-fused pyrimidinyl compounds as anticancer agents

Also Published As

Publication number Publication date
UY29074A1 (es) 2006-03-31
BRPI0514398A (pt) 2008-06-10
US20070249636A1 (en) 2007-10-25
DE602005017283D1 (de) 2009-12-03
EP1781673B1 (de) 2009-10-21
RU2007109867A (ru) 2008-09-27
CA2575056A1 (en) 2006-02-23
AU2005273704A1 (en) 2006-02-23
MX2007001954A (es) 2007-05-09
EP1781673A1 (de) 2007-05-09
TW200621260A (en) 2006-07-01
WO2006018627A1 (en) 2006-02-23
JP2008509976A (ja) 2008-04-03
ZA200701081B (en) 2008-08-27
AR050921A1 (es) 2006-12-06
KR20070046175A (ko) 2007-05-02
CN101023086A (zh) 2007-08-22
IL180811A0 (en) 2007-06-03
NO20070980L (no) 2007-03-12

Similar Documents

Publication Publication Date Title
ATE435859T1 (de) Gyraseinhibitoren und deren verwendungen
DE602005025091D1 (de) Piezooszillator und herstellungsverfahren dafür
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
HRP20220755T3 (hr) Anti-gm-csf antitijela i njihova uporaba
DE602006007831D1 (de) N-alkylcarbonylaminosäureester und n-alkylcarbonylaminosäurelaktonverbindungen und anwendung davon
EP1826209A4 (de) Nitromethylenderivate und deren verwendung
EP1746902A4 (de) Multilektin-affiniätschromatografie und verwendung dafür
DE602006020061D1 (de) Mucin-glycoprotein und anwendung davon
DE602006012060D1 (de) Bicyclische bisamidderivate und deren anwendung als insektizide
EP1731506A4 (de) 5-hydroxyindol-3-carboxylatederivate und deren anwendung
ATE433448T1 (de) Kondensierte heterocyclen und deren verwendungen
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
DE602005021959D1 (de) Substituierte diazaspiroä4.5üdecanderivate und der
ATE476500T1 (de) Neue phospholipasen und deren verwendungen
DE602006011600D1 (de) Audiocodierungseinrichtung und audiocodierungsverfahren
DE602005022751D1 (de) Gleitelement und herstellungsverfahren dafür
ATE493396T1 (de) Neue indazolcarboxamide und ihre verwendung
DE602006014957D1 (de) Audiocodierungseinrichtung und audiocodierungsverfahren
DE602005009200D1 (de) Quecksilberfreisetzende zusammensetzungen und herstellungsverfahren dafür
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
DE602005023325D1 (de) Harzzusammensetzung und formkörper daraus
ATE371653T1 (de) Benzoxazinderivate und deren verwendungen
DE60336025D1 (de) Kollimator und bestrahler
EP1829566A4 (de) Biofilmbildungshemmer und behandlungsvorrichtung
DE10338270B4 (de) Variator und Variatoranordnung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties